2m 2m 2m 2m 2m 2m 2m
Cardinal Health (CAH)
NYSE
$229.00-$0.51 (-0.22%)
Price as of Aug 21, 2026 7:53 PM EDT- $53.1BMarket Cap
- 56.58%1-Year Change
- Medical DistributionIndustry
Cardinal Health (CAH)
$229.00-$0.51 (-0.22%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 254.2B +14.23% | 222.6B -1.87% | 226.8B +10.64% | 205.0B +13.04% | |
Cost of Revenue | 244.5B +14.02% | 214.4B -2.28% | 219.4B +10.75% | 198.1B +13.33% | |
Gross Profit | 9.8B +19.66% | 8.2B +10.17% | 7.4B +7.62% | 6.9B +5.26% | |
Sales and Marketing Expense | 6.1B +13.94% | 5.4B +7.64% | 5.0B +3.43% | 4.8B +6.08% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 956.0M +21.01% | 790.0M +11.27% | 710.0M +2.60% | 692.0M 0.00% | |
Total Operating Expenses | 244.5B +14.02% | 214.4B -2.28% | 219.4B +10.75% | 198.1B +13.33% | |
Operating Profit | 2.6B +14.86% | 2.3B +83.02% | 1.2B +70.98% | 727.0M +221.98% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -348.0M +61.86% | -215.0M +321.57% | -51.0M -45.16% | -93.0M -37.58% | |
Interest Income and Expense and Net | -348.0M +61.86% | -215.0M +321.57% | -51.0M -45.16% | -93.0M -37.58% | |
Total Nonoperating Income and Expense | 31.0M -24.39% | 41.0M +355.56% | 9.0M +125.00% | 4.0M +125.00% | |
Income before Taxes | 2.2B +3.47% | 2.1B +74.94% | 1.2B +88.24% | 638.0M +182.96% | |
Income Taxes | 469.0M -11.84% | 532.0M +52.87% | 348.0M -7.45% | 376.0M +130.67% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 1.7B +9.80% | 1.6B +83.22% | 852.0M +226.44% | 261.0M +127.97% | |
Net Income from Continuing Operations Applicable to Common | 2.2B +3.47% | 2.1B +74.94% | 1.2B +88.24% | 638.0M +182.96% | |
Basic EPS and Net Income | 7.27 +12.19% | 6.48 +86.21% | 3.48 +248.00% | 1.00 +129.85% | |
Diluted EPS and Net Income | 7.23 +12.09% | 6.45 +86.96% | 3.45 +245.00% | 1.00 +129.85% | |
Basic Weighted Average Shares | 236.0M -2.07% | 241.0M -1.63% | 245.0M -6.13% | 261.0M -6.45% | |
Diluted Weighted Average Shares | 237.0M -2.07% | 242.0M -2.02% | 247.0M -5.73% | 262.0M -6.09% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.9B +25.35% | 3.9B -24.53% | 5.1B +26.96% | 4.0B -14.29% | |
Short-Term Investments | N/A N/A | N/A N/A | 200.0M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4.9B +25.35% | 3.9B -27.36% | 5.3B +31.91% | 4.0B -14.29% | |
Total Current Assets | 38.8B +6.54% | 36.4B +4.27% | 34.9B +3.11% | 33.8B +2.73% | |
Accumulated Depreciation | 4.9B +5.95% | 4.7B +11.81% | 4.2B +8.01% | 3.9B +9.51% | |
Property and Plant and Equipment and Net | 3.0B +6.05% | 2.9B +13.01% | 2.5B +2.72% | 2.5B +4.28% | |
Total Long-Term Assets | 1.9B +9.92% | 1.7B +36.25% | 1.3B +20.85% | 1.0B +9.23% | |
Total Assets | 57.3B +7.86% | 53.1B +17.73% | 45.1B +3.92% | 43.4B -1.05% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.9B +242.18% | 550.0M +26.73% | 434.0M -45.20% | 792.0M +36.55% | |
Total Current Liabilities | 43.9B +12.87% | 38.9B +9.14% | 35.6B +5.74% | 33.7B +10.33% | |
Total Long-Term Debt | 7.0B -12.20% | 8.0B +71.25% | 4.7B +19.16% | 3.9B -17.44% | |
Total Long-Term Liabilities | 1.9B +30.64% | 1.5B +60.52% | 917.0M +7.88% | 850.0M -3.19% | |
Total Liabilities | 43.9B +12.87% | 38.9B +9.14% | 35.6B +5.74% | 33.7B +10.33% | |
Retained Earnings | 2.0B +156.58% | 783.0M +373.78% | -286.0M -46.44% | -534.0M +90.71% | |
Total Stockholders Equity | -2.9B +3.67% | -2.8B -13.45% | -3.2B +12.66% | -2.9B +302.26% | |
Total Shares Outstanding | 271.0M 0.00% | 271.0M -17.13% | 327.0M 0.00% | 327.0M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 5.2B +115.85% | 2.4B -36.28% | 3.8B +32.51% | 2.8B -9.06% | |
Capital Expenditures | 649.0M +18.65% | 547.0M +7.05% | 511.0M +6.24% | 481.0M +24.29% | |
Cash from Investing Activities | -2.6B -53.80% | -5.6B +202.49% | -1.8B +307.27% | -454.0M -180.07% | |
Dividends Paid | 491.0M -0.61% | 494.0M -1.00% | 499.0M -4.95% | 525.0M -6.08% | |
Cash from Financing Activities | -1.6B -182.58% | 1.9B +329.04% | -847.0M -72.24% | -3.1B +23.87% | |
Financials Ratio | |||||
Gross Margin | 3.84% +4.76% | 3.67% +12.27% | 3.27% -2.73% | 3.36% -6.89% | |
Operating Margin | 1.03% +0.55% | 1.02% +86.51% | 0.55% +54.54% | 0.35% +207.91% | |
Return on Assets | 3.10% -2.31% | 3.18% +65.11% | 1.92% +221.84% | 0.60% +128.31% | |
Return on Equity | -60.52% +16.20% | -52.09% +85.39% | -28.10% +91.66% | -14.66% -91.50% | |
Revenue Growth | 14.23% +859.59% | -1.87% -117.60% | 10.64% -18.39% | 13.04% +12.10% | |
Current Ratio | 0.88 -5.60% | 0.94 -4.46% | 0.98 -2.49% | 1.00 -6.89% | |
Cash Ratio | 0.11 +11.04% | 0.10 -30.83% | 0.14 +20.10% | 0.12 -22.34% | |
Debt-to-Equity Ratio | -3.08 +0.52% | -3.07 +93.48% | -1.58 -3.85% | -1.65 -78.01% | |
Debt-to-Assets Ratio | 0.16 -3.36% | 0.16 +42.16% | 0.11 +4.25% | 0.11 -10.57% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow